Literature DB >> 21670436

SEPN1-related myopathies: clinical course in a large cohort of patients.

M Scoto1, S Cirak, R Mein, L Feng, A Y Manzur, S Robb, A-M Childs, R M Quinlivan, H Roper, D H Jones, C Longman, G Chow, M Pane, M Main, M G Hanna, K Bushby, C Sewry, S Abbs, E Mercuri, F Muntoni.   

Abstract

OBJECTIVE: To assess the clinical course and genotype-phenotype correlations in patients with selenoprotein-related myopathy (SEPN1-RM) due to selenoprotein N1 gene (SEPN1) mutations for a retrospective cross-sectional study.
METHODS: Forty-one patients aged 1-60 years were included. Clinical data including scoliosis, respiratory function, and growth measurements were collected by case note review.
RESULTS: Mean age at onset was 2.7 years, ranging from birth to the second decade of life. All but 2 remained independently ambulant: one lost ambulation at age 5 years and another in his late 50s. The mean age of starting nocturnal noninvasive ventilation (NIV) was 13.9 years. One child required full-time NIV at the age of 1 year while in 2 cases NIV was started at 33 years. Two patients died from respiratory failure at the age of 10 and 22 years, respectively. The mean age at scoliosis onset was 10 years, in most cases preceded by rigidity of the spine. Fourteen patients had successful spinal surgery (mean age 13.9 years). Twenty-one were underweight; however, overt feeding difficulties were not a feature.
CONCLUSIONS: This study describes the largest population affected by SEPN1-RM reported so far. Our findings show that the spectrum of severity is wider than previously reported. Respiratory insufficiency generally develops by 14 years but may occur as early as in infancy or not until the fourth decade. Motor abilities remain essentially static over time even in patients with early presentation. Most adult patients remain ambulant and fully employed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21670436     DOI: 10.1212/WNL.0b013e31821f467c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  SEPN1-related Rigid Spine Muscular Dystrophy.

Authors:  Arushi Gahlot Saini; Hansashree Padmanabha; Senthil Kumar; Naveen Sankhyan; Pratibha Singhi
Journal:  Indian J Pediatr       Date:  2018-05-31       Impact factor: 1.967

Review 2.  Congenital myopathies: an update.

Authors:  Jessica R Nance; James J Dowling; Elizabeth M Gibbs; Carsten G Bönnemann
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

3.  SEPN1-related myopathy in three patients: novel mutations and diagnostic clues.

Authors:  Anna Ardissone; Cinzia Bragato; Flavia Blasevich; Elio Maccagnano; Franco Salerno; Claudia Gandioli; Lucia Morandi; Marina Mora; Isabella Moroni
Journal:  Eur J Pediatr       Date:  2016-01-16       Impact factor: 3.183

Review 4.  Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.

Authors:  Gianina Ravenscroft; Nigel G Laing; Carsten G Bönnemann
Journal:  Brain       Date:  2014-12-31       Impact factor: 13.501

5.  Congenital myopathies: Natural history of a large pediatric cohort.

Authors:  Irene Colombo; Mariacristina Scoto; Adnan Y Manzur; Stephanie A Robb; Lorenzo Maggi; Vasantha Gowda; Thomas Cullup; Michael Yau; Rahul Phadke; Caroline Sewry; Heinz Jungbluth; Francesco Muntoni
Journal:  Neurology       Date:  2014-11-26       Impact factor: 9.910

6.  Early Onset of Sleep-Disordered Breathing in Two Children With SEPN1-Related Myopathies.

Authors:  Mathilde Viprey; Ha Trang; Michaël Pomedio; Katia Bessaci-Kabouya; Pascal Sabouraud; Fawzia Cheliout-Heraut; Pierre Mauran
Journal:  J Clin Sleep Med       Date:  2017-09-15       Impact factor: 4.062

Review 7.  Selenoprotein N in skeletal muscle: from diseases to function.

Authors:  Perrine Castets; Alain Lescure; Pascale Guicheney; Valérie Allamand
Journal:  J Mol Med (Berl)       Date:  2012-04-14       Impact factor: 4.599

8.  Selenoprotein N deficiency in mice is associated with abnormal lung development.

Authors:  Behzad Moghadaszadeh; Branden E Rider; Michael W Lawlor; Martin K Childers; Robert W Grange; Kushagra Gupta; Steve S Boukedes; Caroline A Owen; Alan H Beggs
Journal:  FASEB J       Date:  2013-01-16       Impact factor: 5.191

9.  ASC-1 Is a Cell Cycle Regulator Associated with Severe and Mild Forms of Myopathy.

Authors:  Rocío N Villar-Quiles; Fabio Catervi; Eva Cabet; Raul Juntas-Morales; Casie A Genetti; Teresa Gidaro; Asuman Koparir; Adnan Yüksel; Sandra Coppens; Nicolas Deconinck; Emma Pierce-Hoffman; Xavière Lornage; Julien Durigneux; Jocelyn Laporte; John Rendu; Norma B Romero; Alan H Beggs; Laurent Servais; Mireille Cossée; Montse Olivé; Johann Böhm; Isabelle Duband-Goulet; Ana Ferreiro
Journal:  Ann Neurol       Date:  2019-12-27       Impact factor: 10.422

Review 10.  Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction.

Authors:  Heinz Jungbluth; Susan Treves; Francesco Zorzato; Anna Sarkozy; Julien Ochala; Caroline Sewry; Rahul Phadke; Mathias Gautel; Francesco Muntoni
Journal:  Nat Rev Neurol       Date:  2018-02-02       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.